{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:56:23Z","timestamp":1790762183616,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rigshospitalet Research Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Monocytes play an important role in inflammation, and monocytosis and monocyte activation are features of chronic inflammation. We aimed to investigate if HIV status was associated with monocyte count and monocyte activation and to assess the relationship between monocyte count and monocyte activation markers and HIV-related factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Persons living with HIV (PLWH) with measured monocyte count and sCD14 and sCD163 were included from the Copenhagen Comorbidity in HIV infection (COCOMO) study and matched 1:5 on sex and age with uninfected controls. In addition, 74 uninfected individuals from COCOMO with measured sCD14 and sCD163 were included. Identical protocols and equipment were used to determine monocyte counts and monocyte activation in PLWH and uninfected controls. Linear regression adjusted for age, sex, smoking and waist-to-hip-ratio was used to analyze the association between possible risk factors and monocyte outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included 871 PLWH and 4355 uninfected controls. PLWH had \u2212\u00a00.021 [\u2212\u00a00.031 \u2212\u00a00.011]\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L) lower monocyte count than uninfected controls, and in adjusted analyses HIV status was independently associated with \u2212\u00a00.035 [\u2212\u00a00.045, \u2212\u00a00.025]\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L lower monocyte count. In contrast, PLWH had higher sCD163 and sCD14 concentrations than uninfected controls. After adjustment, HIV-status was associated with higher sCD14 and sCD163 concentrations (588 [325, 851] ng\/ml, and 194 [57, 330] ng\/ml, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PLWH had lower monocyte counts than controls, but the absolute difference was small, and any clinical impact is likely limited. In contrast, concentrations of monocyte activation markers, previously implicated as drivers of non-AIDS comorbidity, were higher in PLWH than in controls.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07450-y","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T14:03:30Z","timestamp":1652277810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls"],"prefix":"10.1186","volume":"22","author":[{"given":"Andreas D.","family":"Knudsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Bouazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gelpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Benfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"H\u00f8gh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda Teresa","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Tr\u00f8seid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne D.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"issue":"2","key":"7450_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/QAI.0000000000000825","volume":"71","author":"RA Legarth","year":"2016","unstructured":"Legarth RA, Ahlstr\u00f6m MG, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study. J Acquir Immune Defic Syndr. 2016;71(2):213\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"7450_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7954","volume":"3","author":"JL Marcus","year":"2020","unstructured":"Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000\u20132016. JAMA Netw open. 2020;3(6): e207954.","journal-title":"JAMA Netw open"},{"issue":"12","key":"7450_CR3","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cid\/ciu701","volume":"59","author":"J Schouten","year":"2014","unstructured":"Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787\u201397. https:\/\/doi.org\/10.1093\/cid\/ciu701.","journal-title":"Clin Infect Dis"},{"key":"7450_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy146","author":"M Gelpi","year":"2018","unstructured":"Gelpi M, Afzal S, Lundgren J, Ronit A, Roen A, Mocroft A, et al. Higher risk of abdominal obesity, elevated LDL cholesterol and hypertriglyceridemia, but not of hypertension, in people living with HIV: results from the Copenhagen comorbidity in HIV infection (COCOMO) study. Clin Infect Dis. 2018. https:\/\/doi.org\/10.1093\/cid\/ciy146.","journal-title":"Clin Infect Dis"},{"key":"7450_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000695","author":"MJ Feinstein","year":"2019","unstructured":"Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association. Circulation. 2019. https:\/\/doi.org\/10.1161\/CIR.0000000000000695.","journal-title":"Circulation"},{"issue":"10","key":"7450_CR6","doi-asserted-by":"publisher","first-page":"e652","DOI":"10.1016\/S2352-3018(21)00156-9","volume":"8","author":"J Shuter","year":"2021","unstructured":"Shuter J, Reddy KP, Hyle EP, Stanton CA, Rigotti NA. Harm reduction for smokers living with HIV. Lancet HIV. 2021;8(10):e652\u20138.","journal-title":"Lancet HIV."},{"key":"7450_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ013","author":"LD Rasmussen","year":"2015","unstructured":"Rasmussen LD, Helleberg M, May MT, Afzal S, Kronborg G, Larsen CS, et al. Myocardial infarction among danish HIV-infected individuals: population-attributable fractions associated with smoking. Clin Infect Dis. 2015. https:\/\/doi.org\/10.1093\/cid\/civ013.","journal-title":"Clin Infect Dis"},{"key":"7450_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-020-00484-4","author":"TR Butterfield","year":"2020","unstructured":"Butterfield TR, Landay AL, Anzinger JJ. dysfunctional immunometabolism in HIV infection: contributing factors and implications for age-related comorbid diseases. Curr HIV\/AIDS Rep. 2020. https:\/\/doi.org\/10.1007\/s11904-020-00484-4.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"7450_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01378","author":"A Jaworowski","year":"2019","unstructured":"Jaworowski A, Hearps AC, Angelovich TA, Hoy JF. How monocytes contribute to increased risk of atherosclerosis in virologically-suppressed HIV-positive individuals receiving combination antiretroviral therapy. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.01378.","journal-title":"Front Immunol"},{"key":"7450_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir520","author":"TH Burdo","year":"2011","unstructured":"Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011. https:\/\/doi.org\/10.1093\/infdis\/jir520.","journal-title":"J Infect Dis"},{"key":"7450_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx108","author":"T Booiman","year":"2017","unstructured":"Booiman T, Wit FW, Maurer I, De Francesco D, Sabin CA, Harskamp AM, et al. High cellular monocyte activation in people living with human immunodeficiency virus on combination antiretroviral therapy and lifestyle-matched controls is associated with greater inflammation in cerebrospinal fluid. Open Forum Infect Dis. 2017. https:\/\/doi.org\/10.1093\/ofid\/ofx108.","journal-title":"Open Forum Infect Dis"},{"key":"7450_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/569819","author":"JJ Anzinger","year":"2014","unstructured":"Anzinger JJ, Butterfield TR, Angelovich TA, Crowe SM, Palmer CS. Monocytes as regulators of inflammation and HIV-related comorbidities during cART. J Immunol Res. 2014. https:\/\/doi.org\/10.1155\/2014\/569819.","journal-title":"J Immunol Res"},{"issue":"10","key":"7450_CR13","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/QAD.0000000000000735","volume":"29","author":"CL Shive","year":"2015","unstructured":"Shive CL, Jiang W, Anthony DD, Lederman MM. Soluble CD14 is a nonspecific marker of monocyte activation. AIDS. 2015;29(10):1263\u20135.","journal-title":"AIDS"},{"key":"7450_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu594","author":"RA McKibben","year":"2015","unstructured":"McKibben RA, Margolick JB, Grinspoon S, Li X, Palella FJ, Kingsley LA, et al. Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection. J Infect Dis. 2015. https:\/\/doi.org\/10.1093\/infdis\/jiu594.","journal-title":"J Infect Dis"},{"key":"7450_CR15","doi-asserted-by":"crossref","unstructured":"Longenecker CT, Jiang Y, Orringer CE, Gilkeson RC, Debanne S, Funderburg NT, et al. Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection. AIDS. 2014; 28(7):969-77","DOI":"10.1097\/QAD.0000000000000158"},{"key":"7450_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir214","author":"TH Burdo","year":"2011","unstructured":"Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, et al. Soluble CD163 made by monocyte\/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after antiretroviral therapy. J Infect Dis. 2011. https:\/\/doi.org\/10.1093\/infdis\/jir214.","journal-title":"J Infect Dis"},{"key":"7450_CR17","unstructured":"Saumoy M, Sanchez-Quesada J, Di Yacovo S, Ferrer E, Imaz A, Garcia B, et al. Inflammatory biomarkers related with subclinical atherosclerosis in suppressed HIV-infected patients. J Int AIDS Soc Conf 2018 Int Congr drug Ther HIV Infect HIV Glas 2018 United kingdom. 2018;"},{"key":"7450_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158169","author":"A Castley","year":"2016","unstructured":"Castley A, Williams L, James I, Guelfi G, Berry C, Nolan D. Plasma CXCL10, sCD163 and sCD14 levels have distinct associations with antiretroviral treatment and cardiovascular disease risk factors. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0158169.","journal-title":"PLoS ONE"},{"key":"7450_CR19","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2015.0012","author":"B Williams","year":"2016","unstructured":"Williams B, Livak B, Bahk M, Keating SM, Adeyemi OM. Short communication: SCD14 and SCD163 levels are correlated with VACS index scores: initial data from the blunted immune recovery in CORE patients with HIV (BIRCH) cohort. AIDS Res Hum Retroviruses. 2016. https:\/\/doi.org\/10.1089\/aid.2015.0012.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"7450_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu254","author":"AR Tenorio","year":"2014","unstructured":"Tenorio AR, Zheng Y, Bosch RJ, Krishnan S, Rodriguez B, Hunt PW, et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis. 2014. https:\/\/doi.org\/10.1093\/infdis\/jiu254.","journal-title":"J Infect Dis"},{"key":"7450_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix082","author":"DB Hanna","year":"2017","unstructured":"Hanna DB, Lin J, Post WS, Hodis HN, Xue X, Anastos K, et al. Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men. J Infect Dis. 2017. https:\/\/doi.org\/10.1093\/infdis\/jix082.","journal-title":"J Infect Dis"},{"key":"7450_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv145","author":"E Krastinova","year":"2015","unstructured":"Krastinova E, Lecuroux C, Leroy C, Seng R, Cabie A, Rami A, et al. High soluble CD14 levels at primary HIV-1 infection predict more rapid disease progression. J Infect Dis. 2015. https:\/\/doi.org\/10.1093\/infdis\/jiv145.","journal-title":"J Infect Dis"},{"issue":"6","key":"7450_CR23","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1182\/blood.V92.6.2084.418k26_2084_2092","volume":"92","author":"E Lien","year":"1998","unstructured":"Lien E, Aukrust P, Sundan A, M\u00fcller F, Fr\u00f8land SS, Espevik T. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: Correlation to disease progression and clinical events. Blood. 1998;92(6):2084\u201392.","journal-title":"Blood"},{"issue":"1","key":"7450_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1186\/s12879-016-2026-9","volume":"16","author":"A Ronit","year":"2016","unstructured":"Ronit A, Haissman J, Kirkegaard-Klitbo DM, Kristensen TS, Lebech A-M, Benfield T, et al. Copenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark. BMC Infect Dis. 2016;16(1):713. https:\/\/doi.org\/10.1186\/s12879-016-2026-9.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"7450_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299\u2013308.","journal-title":"JAMA"},{"key":"7450_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3","author":"WHO","year":"2004","unstructured":"WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies: report of a WHO Expert consultation. Lancet. 2004. https:\/\/doi.org\/10.1016\/S0140-6736(03)15268-3.","journal-title":"Lancet"},{"key":"7450_CR27","unstructured":"Consultation WHOE. Waist circumference and waist-hip ratio report of a WHO expert consultation. World Health. 2008;"},{"key":"7450_CR28","doi-asserted-by":"crossref","unstructured":"JNC 8. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320.","DOI":"10.1001\/jama.2013.284427"},{"key":"7450_CR29","unstructured":"R: A language and environment for statistical computing. R Core Team. R Foundation for Statistical Computing, Vienna, Austria. [Internet]. 2019. http:\/\/www.r-project.org."},{"key":"7450_CR30","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP50AEEYGREWUZ","author":"EP Weinzierl","year":"2013","unstructured":"Weinzierl EP, Arber DA. The differential diagnosis and bone marrow evaluation of new-onset pancytopenia. Am J Clin Pathol. 2013. https:\/\/doi.org\/10.1309\/AJCP50AEEYGREWUZ.","journal-title":"Am J Clin Pathol"},{"key":"7450_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01693","author":"KM Merino","year":"2017","unstructured":"Merino KM, Allers C, Didier ES, Kuroda MJ. Role of monocyte\/macrophages during HIV\/SIV infection in adult and pediatric acquired immune deficiency syndrome. Front Immunol. 2017. https:\/\/doi.org\/10.3389\/fimmu.2017.01693.","journal-title":"Front Immunol"},{"issue":"15","key":"7450_CR32","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1097\/QAD.0000000000000408","volume":"28","author":"JH Campbell","year":"2014","unstructured":"Campbell JH, Hearps AC, Martin GE, Williams KC, Crowe SM. The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure. AIDS. 2014;28(15):2175.","journal-title":"AIDS"},{"key":"7450_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01435","author":"ME Wong","year":"2019","unstructured":"Wong ME, Jaworowski A, Hearps AC. The HIV reservoir in monocytes and macrophages. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.01435.","journal-title":"Front Immunol"},{"key":"7450_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2109","author":"CC Carter","year":"2010","unstructured":"Carter CC, Onafuwa-Nuga A, McNamara LA, Riddell J, Bixby D, Savona MR, et al. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med. 2010. https:\/\/doi.org\/10.1038\/nm.2109.","journal-title":"Nat Med"},{"issue":"5","key":"7450_CR35","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1182\/blood.V90.5.1787","volume":"90","author":"I Bahner","year":"1997","unstructured":"Bahner I, Kearns K, Coutinho S, Leonard EH, Kohn DB. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV- 1) is both required and sufficient for HIV-1-lnduced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood. 1997;90(5):1787\u201398.","journal-title":"Blood"},{"key":"7450_CR36","doi-asserted-by":"publisher","DOI":"10.1086\/514149","author":"V Gill","year":"1997","unstructured":"Gill V, Shattock RJ, Scopes J, Hayes P, Freedman AR, Griffin GE, et al. Human immunodeficiency virus infection impairs hemopoiesis in long-term bone marrow cultures: Nonreversal by nucleoside analogues. J Infect Dis. 1997. https:\/\/doi.org\/10.1086\/514149.","journal-title":"J Infect Dis"},{"key":"7450_CR37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-204263","author":"A Hasegawa","year":"2009","unstructured":"Hasegawa A, Liu H, Ling B, Borda JT, Alvarez X, Sugimoto C, et al. The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood. 2009. https:\/\/doi.org\/10.1182\/blood-2009-02-204263.","journal-title":"Blood"},{"issue":"6","key":"7450_CR38","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1189\/jlb.4A0914-441R","volume":"97","author":"Y Cai","year":"2015","unstructured":"Cai Y, Sugimoto C, Liu DX, Midkiff CC, Alvarez X, Lackner AA, et al. Increased monocyte turnover is associated with interstitial macrophage accumulation and pulmonary tissue damage in SIV-infected rhesus macaques. J Leukoc Biol. 2015;97(6):1147\u201353.","journal-title":"J Leukoc Biol"},{"key":"7450_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103129","volume":"62","author":"S Novelli","year":"2020","unstructured":"Novelli S, L\u00e9curoux C, Goujard C, Reynes J, Villemant A, Blum L, et al. Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection. EBioMedicine. 2020;62: 103129.","journal-title":"EBioMedicine"},{"issue":"4","key":"7450_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","volume":"29","author":"NI Wada","year":"2015","unstructured":"Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015;29(4):463\u201371.","journal-title":"AIDS"},{"issue":"4","key":"7450_CR41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/JLB.3A0717-294RR","volume":"103","author":"JC Williams","year":"2018","unstructured":"Williams JC, Zhang X, Karki M, Chi Y-Y, Wallet SM, Rudy BJ, et al. Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls. J Leukoc Biol. 2018;103(4):671\u201380.","journal-title":"J Leukoc Biol"},{"key":"7450_CR42","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00087708","author":"V Regueiro","year":"2009","unstructured":"Regueiro V, Campos MA, Morey P, Sauleda J, Agust\u00ed AGN, Garmendia J, et al. Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers. Eur Respir J. 2009. https:\/\/doi.org\/10.1183\/09031936.00087708.","journal-title":"Eur Respir J"},{"key":"7450_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.6698","author":"S Subramanian","year":"2012","unstructured":"Subramanian S, Tawakol A, Burdo TH, Abbara S, Wei J, Vijayakumar J, et al. Arterial inflammation in patients with HIV. JAMA. 2012. https:\/\/doi.org\/10.1001\/jama.2012.6698.","journal-title":"JAMA"},{"issue":"3","key":"7450_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/QAI.0000000000001795","volume":"79","author":"AD Knudsen","year":"2018","unstructured":"Knudsen AD, Gelpi M, Afzal S, Ronit A, Roen A, Mocroft A, et al. Prevalence of peripheral artery disease is higher in persons living with HIV compared with uninfected controls. J Acquir Immune Defic Syndr. 2018;79(3):381\u20135.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7450_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097698","author":"R Valiathan","year":"2014","unstructured":"Valiathan R, Miguez MJ, Patel B, Arheart KL, Asthana D. Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0097698.","journal-title":"PLoS ONE"},{"key":"7450_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw459","author":"KW Kooij","year":"2016","unstructured":"Kooij KW, Wit FWNM, Booiman T, Van Der Valk M, Van Der Loeff MFS, Kootstra NA, et al. Cigarette smoking and inflammation, monocyte activation, and coagulation in HIV-infected individuals receiving antiretroviral therapy, compared with uninfected individuals. J Infect Dis. 2016. https:\/\/doi.org\/10.1093\/infdis\/jiw459.","journal-title":"J Infect Dis"},{"key":"7450_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000759","author":"PA Cioe","year":"2015","unstructured":"Cioe PA, Baker J, Kojic EM, Onen N, Hammer J, Patel P, et al. Elevated soluble CD14 and lower D-dimer are associated with cigarette smoking and heavy episodic alcohol use in persons living with HIV. J Acquir Immune Defic Syndr. 2015. https:\/\/doi.org\/10.1097\/QAI.0000000000000759.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7450_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(02)03142-3","author":"W Frings","year":"2002","unstructured":"Frings W, Dreier J, Sorg C. Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect. FEBS Lett. 2002. https:\/\/doi.org\/10.1016\/s0014-5793(02)03142-3.","journal-title":"FEBS Lett"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07450-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07450-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07450-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T14:03:56Z","timestamp":1652277836000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07450-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7450"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07450-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent. Both the COCOMO study (H-8-2014-0004) and the CGPS study (H-KF-01-144\/01) have obtained approval from the Ethics Committee of the Capital Region and from the Danish Data Protection Agency. All methods were performed in accordance with relevant guidelines and regulations and in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.D.K has received a grant from The Danish Heart Foundation and a travelling grant from Gilead unrelated to this manuscript; S.D.N. has received unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, Rigshospitalet Research Council. Travelling grants from Gilead. Advisory board activity for Gilead and GSK\/ViiV, all unrelated to this manuscript. All other authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"451"}}